靛玉红(indjrubjn)是中药青黛的一种有效成分,我国首创,用于治疗慢性粒细胞性白血病(下称慢粒),且认为它是一种副作用小、安全度大的抗白血病药物。我们应用于骨髓增殖性疾病中,发现2例出现较严重的毒副反应,现报告如下。病例摘要例1 莫某,男,31岁。1981年11月3日入院,住院号35858。4个月前因患感冒,体检时发现脾脏肿大,白细胞22万,并作了骨髓穿刺,诊断为 Indjrubjn is an active ingredient of Chinese Herbal Medicine Indigo natural, the first of its kind used in the treatment of chronic myelogenous leukemia (hereinafter referred to as CML), and is considered as an anti-leukemia drug with small side effects and high safety. We applied to myeloproliferative diseases and found two cases of more serious side effects, are as follows. Case summary 1 Momo, male, 31 years old. November 3, 1981 admission, hospitalization 35858.4 months ago due to influenza, physical examination found splenomegaly, leukocytes 220,000, and made a bone marrow puncture, the diagnosis of